Drugs Made In America Acquisition II Unit Financial Ratios
NASDAQ: DMIIUFinancial ServicesShell CompaniesUSD
10.23-0.0199 (-0.19%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Drugs Made In America Acquisition II Unit ratio analysis
Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Drugs Made In America Acquisition II Unit financial ratios (annual)
| Ratio | FY 2025 |
|---|---|
| Return on assets (ROA) | 0.8% |
| Current ratio | 0.09 |